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Background  and purpose:  The  role  of  an  arterial  blood  gas  analysis  in acute  heart  failure (AHF)  remains
unclear.  The  acid–base  balance  could  help  to treat  AHF,  and  it might  help  to distinguish  different  types of
AHF, while  it might  be associated  with  the  AHF  prognosis.  The  present  study  was  conducted  to  determine
the  relationship  between  the  arterial  blood  gas  sample  at the  time  of  hospital  admission  and  clinical
ﬁndings  on admission,  outcomes.
Methods  and  results:  Six  hundred  twenty-one  patients  with  AHF  admitted  to  the  intensive  care  unit
were  analyzed.  Patients  were  assigned  to an  alkalosis  group  (n  =  99,  pH  >  7.45),  normal  group  (n  =  178,
7.35    pH   7.45),  and  acidosis  group  (n =  344,  pH < 7.35).  The  clinical  ﬁndings  on  admission  and  outcomes
(in-hospital  mortality  and  any-cause  death  within  2 years)  were  compared  between  the  three  groups.
The  white  blood  cell  counts  (WBC),  serum  levels  of  total  protein,  albumin,  and  glucose  were  signiﬁcantly
lower,  and  the  serum  levels  of C-reactive  protein  (CRP)  and total  bilirubin  were  signiﬁcantly  higher  in  the
alkalosis  group.  Patients  with  orthopnea  were  signiﬁcantly  fewer,  and  the  systolic  blood  pressure  (SBP)
and heart  rate  (HR)  were  signiﬁcantly  lower  in  the  alkalosis  group.  The  results  of  a multivariate  logistic
regression  model  for  in-hospital  mortality  found  that  alkalosis  was  an  independent  risk  factor  (p  =  0.017,
odds ratio:  2.589;  95% conﬁdence  interval:  1.186–5.648).  The  Kaplan–Meier  curves  showed  the  prognosis
for  any-cause  death  to  be signiﬁcantly  poorer  in  the  alkalosis  group  than  in  the  normal  group  (p =  0.026).
Conclusions:  The  factors  associated  with  alkalosis  AHF  were  high  CRP,  bilirubin,  and  low  WBC,  glucose,
total  protein,  and  albumin.  The  patients  with  alkalosis  AHF  were  less  likely  to  have  orthopnea  with  low
SBP and  HR.  They  suggested  that  the patients  with  alkalosis  AHF  might  have  experienced  AHF for  a few
days  and  were  associated  with  high  mortality.
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The European Society of Cardiology (ESC) and the Ameri-
an College of Cardiology Foundation/American Heart Association
ACCF/AHA) heart failure (HF) guidelines deﬁne acute HF (AHF)
s a rapid onset of or deterioration in the signs and symptoms
f HF [1,2]. Therefore, dyspnea is the most frequent complaint of
atients with AHF [3]. An arterial blood gas analysis (ABG) is one
f the main tools for decision-making in patients with dyspnea,
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ax: +81 476 99 1911.
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such as chronic obstructive pulmonary disease exacerbation [4] or
bronchial asthma [5],  in an emergency setting. Furthermore, the
ABG is usually performed to evaluate acid–base balance for the
treatment of patients with AHF in the emergency setting. The ESC
guidelines also recommended assessing ABG in patients with AHF
[1]. However, the role of the acid–base balance is rarely considered
in AHF, since there is little evidence in the literature demonstrating
any association with the clinical ﬁndings, including a poor progno-
sis. Min˜ana et al. reported that pO2, pCO2, and pH at the time of
admission are not associated with all-cause long-term mortality
[6]. In addition, the prognostic value of ABG in patients with AHF
has not yet been established.
We hypothesized that the acid–base balance could help to dis-
tinguish different types of AHF, while it is also considered to
be associated with the AHF prognosis. The present study was
vier Ltd. All rights reserved.
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onducted to determine the relationship between the ABG sample
t the time of hospital admission and clinical ﬁndings on admis-
ion, medications prescribed during the ﬁrst 5 days, and outcomes
in-hospital mortality and any-cause death within 2 years).
ethods
ubjects
This study analyzed six hundred twenty-one consecutive
atients with AHF who were admitted to the intensive care unit of
hiba Hokusoh Hospital, Nippon Medical School between January
000 and April 2011. The data were retrospectively evaluated from
he hospital medical records, and all AHF patients for whom ABG
amples could be obtained were enrolled. AHF was  deﬁned as either
ew-onset HF or decompensation of chronic HF with symptoms
ufﬁcient to warrant hospitalization [7].  HF was  diagnosed based
n the Framingham criteria for a clinical diagnosis of HF, based on
he satisfaction of 2 major criteria or 1 major and 2 minor crite-
ia [8]. Any patients with HF caused by acute coronary syndrome
ere excluded from the study. In addition, only the ﬁrst admission
as considered for patients who were readmitted to the intensive
are unit during the two-year period after their discharge. All cases
nderwent an ABG analysis including pH, pCO2, pO2, HCO3−, BE,
nd SaO2 in the emergency setting within 30 min  after admission.
rocedures
The patients were assigned to an alkalosis group (n = 99,
H > 7.45), a normal acid–base balance group (n = 178,
.35  pH  7.45), and an acidosis group (n = 344, pH < 7.35)
ased on an ABG analysis in an emergency setting within 30 min
f their admission.
The study examined (1) any differences in the patients’ char-
cteristics and treatments between the three groups, (2) the
orrelation between acid–base balance and the clinical information
ncluding age, type of HF (new onset or worsening), etiology of HF
ischemia or non-ischemia), gender, orthopnea (yes or no), white
lood cells (WBC), total protein, albumin, blood urea nitrogen, total
ilirubin, sodium, potassium, hemoglobin, C-reactive protein (CRP),
ystolic blood pressure (SBP), clinical scenarios (CS) [9],  heart rate
HR), and (3) the relationship between the acid–base balance and
hort-term (in-hospital mortality) and long-term (any-cause death
ithin 2 years) mortality.
New onset HF was deﬁned as the ﬁrst admission for HF, and
orsening HF was deﬁned as having a history of hospital admission
aused by HF. The CS was deﬁned based on a previous report: CS 1,
yspnea and/or congestion with systolic blood pressure >140 mm
g; CS 2, dyspnea and/or congestion with systolic blood pressure
00–140 mmHg; CS 3, dyspnea and/or congestion with systolic
lood pressure <100 mm  Hg [9].
cid–base balance and prognosis
The signiﬁcant factors associated with in-hospital mortality
ere determined by a multivariate logistic regression model. All
ariables on admission including age, type of HF (new onset
r worsening), etiology of HF (ischemia or non-ischemia), gen-
er, orthopnea (yes or no), WBC, total protein, albumin, blood
rea nitrogen, creatinine, total bilirubin, sodium, potassium,
emoglobin, CRP, SBP, HR, ABG that were retrieved from all 621
ases were selected to evaluate in the multivariate logistic regres-
ion model. The continuous variables were evaluated by dividing
wo groups using cutoff values. The cutoff value of the continu-
us variables was decided by the median value. Finally, the factors
hat were signiﬁcantly correlated with acid–base balance werediology 60 (2012) 288–294 289
excluded from the evaluation of the multivariate logistic regression
model.
The patients were clinically followed-up for 2 years at a routine
outpatient clinic. The prognosis of patients followed up at another
hospital was  determined by telephoning the other hospital. The
relationships between the acid–base balance and any-cause death
within 2 years were investigated. The survival rates were analyzed
using Kaplan–Meier curves according to the acid–base balance.
Statistical analysis
All data were statistically analyzed using the StatView 5 soft-
ware package (SAS Institute, Cary, NC, USA), and the SPSS 14.0 J
software program (SPSS Japan Institute, Tokyo, Japan).
All numerical data were expressed as the means ± standard
deviation. Unpaired Student’s t-test or the one-way analysis of vari-
ance (ANOVA) was used to compare mean values. Comparisons
of all proportions were performed with a chi-square analysis. A
Jonckheere–Terpstra analysis was used to compare the mean val-
ues between the alkalosis, normal, and acidosis groups. A p-value
of <0.05 was deﬁned to be statistically signiﬁcant. The correlation
of the acid–base balance with the WBC  counts, serum levels of CRP,
total protein, albumin, total bilirubin, and glucose were analyzed
by Spearman’s correlation test. The correlation of the acid–base
balance with the SBP and HR was  also analyzed by Spearman’s cor-
relation test. A p-value of <0.001, and an r value of −0.3 or 0.3
were deﬁned as being statistically signiﬁcant.
The signiﬁcant factors for indicating in-hospital mortality
were determined by the multivariate logistic regression model.
The survival rates between three groups were analyzed using
Kaplan–Meier curves according to the acid–base balance, and sig-
niﬁcant differences were calculated using the log-rank test.
Ethical concerns
The institutional review board at Chiba Hokusoh Hospital, Nip-
pon Medical School approved the study protocol.
Results
Acid–base balance and the clinical information on admission
The serum levels of pH, pCO2, pO2, HCO3−, BE, and SaO2 are
shown in Table 1. The amount of O2 inhalation on initial admission
was signiﬁcantly lower in the alkalosis group than in the acidosis
group. The pH levels were signiﬁcantly higher, pCO2 levels were
signiﬁcantly lower, BE and HCO3− levels were signiﬁcantly higher
in the alkalosis group than in the acidosis group.
The relationship between the patient characteristics, including
baseline values on admission, and the acid–base balance is shown
in Table 2. The patient cohort was 66.5% males, with a mean age of
71.9 ± 11.6 years old. Two  hundred and ﬁfty-seven (41.4%) of the
patients had ischemic heart disease, and 364 (58.6%) patients had
non-ischemic heart diseases, including cardiomyopathy (n = 98),
hypertensive heart disease (n = 115), valvular disease (n = 135), and
other heart diseases (n = 16), and the etiology of HF was  similar
in each group. Most patients had orthopnea (80.8%); the patients
demonstrating alkalosis were less likely to have orthopnea (52.5%)
than those in the normal (60.6%) and acidosis (94.2%) groups.
The WBC  counts were signiﬁcantly lower in the alkalosis group
than in the acidosis group; however, the serum levels of CRP were
signiﬁcantly higher in the alkalosis group than in the acidosis group.
The serum levels of total protein and albumin were signiﬁcantly
lower in the alkalosis group than in the acidosis group. Serum levels
of total bilirubin were signiﬁcantly higher in the alkalosis group
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Table  1
Comparison of arterial blood gas between three groups.
All (n = 621) Alkalosis (n = 99) Normal (n = 178) Acidosis (n = 344) p value
Arterial blood gas
pH 7.30 ± 0.16 7.49 ± 0.04 7.40 ± 0.03 7.19 ± 0.12 <0.001
pCO2 (mmHg) 49.3 ± 26.9 30.4 ± 6.3 40.3 ± 34.5 59.3 ± 20.9 <0.001
pO2 (mmHg) 113 ± 84.1 104 ± 74.2 100 ± 63.3 122 ± 94.6 <0.001
HCO3 (mmol/L) 21.8 ± 4.6 22.4 ± 5.7 22.6 ± 3.7 21.2 ± 4.6 0.048
BE  (mmol/L) −3.7 ± 6.1 0.6 ± 6.7 −0.9 ± 4.1 −6.4 ± 5.5 <0.001
SaO2 (%) 92.5 ± 7.9 95.8 ± 3.9 94.0 ± 5.2 90.8 ± 9.4 <0.001
Amount of O2 inhalation (L) 7.83 ± 3.72 4.57 ± 4.03 6.81 ± 4.04 9.29 ± 2.50 <0.001
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p value; comparison with alkalosis, normal acid balance and acidosis groups by the
han in the acidosis group, and glucose was signiﬁcantly lower in
he alkalosis group than in the acidosis group.
The SBP was signiﬁcantly lower in the alkalosis
roup (132.1 ± 29.9 mmHg) than in the acidosis group
172.5 ± 42.7 mmHg); furthermore, HR was lower in the alka-
osis group (108.5 ± 32.8 beat/min) than in the acidosis group
117.0 ± 28.5 beat/min). The cases of CS 1 were signiﬁcantly more
n the acidosis group, on the other hand, the cases of CS 2 and CS 3
ere signiﬁcantly more in the alkalosis group.
The relationship between the acid–base balance and their
linical information and vital signs are shown in Fig. 1. The
BC  counts, serum level of glucose, and SBP had a signiﬁ-
ant negative correlation with the pH value (p < 0.001, WBC:
 = −0.416, glucose: r = −0.507, SBP: r = −0.380); furthermore, the
erum level of total bilirubin was signiﬁcantly correlated with
he pH value (p < 0.001, r = 0.365). On the other hand, serum
evel of total protein and albumin had a weak negative cor-
elation with the pH value (p < 0.001, total protein: r = −0.270,
lbumin: r = −0.273, HR: r = −0.181), and the serum level of
RP had also a weak correlation with the pH value (p < 0.001,
 = 0.191).
able 2
atients’ characteristics on admission.
Characteristics All (n = 621) Alkalosis (n = 
Age (years old) 71.9 ± 11.6 70.2 ± 11.7
Type  (new onset, %) 466 (75.0%) 79 (79.8%) 
Etiology (non-ischemia, %) 364 (58.6%) 60 (60.6%) 
Gender (male, %) 413 (66.5%) 69 (69.7%) 
Orthopnea (yes, %) 500 (80.5%) 52 (52.5%) 
WBC  (/l) 10,604 ± 5,489 8,696 ± 3,169 
CRP  (mg/dl) 1.82 ± 3.34 3.54 ± 4.2
Total  protein (g/dl) 6.74 ± 0.71 6.49 ± 0.7
Albumin (g/dl) 3.71 ± 0.48 3.46 ± 0.4
BUN  (mg/dl) 26.7 ± 13.4 26.3 ± 15.4
Creatinine (mg/dl) 1.38 ± 0.86 1.25 ± 0.4
Sodium (mmol/l) 139.3 ± 4.2 138.3 ± 4.7 
Potassium (mmol/l) 4.30 ± 0.72 4.14 ± 0.6
Hemoglobin (g/dl) 12.7 ± 2.8 12.5 ± 3.1 
Total  bilirubin (mg/dl) 0.80 ± 1.03 1.26 ± 1.4
glucose (mg/dl) 208.9 ± 95.6 152.4 ± 66.3
Urinary acid (mg/dl) 6.91 ± 2.18 7.18 ± 2.2
BNP  (pg/ml) 1051.0 ± 1149.4 1283.6 ± 1669
Systolic blood pressure (mmHg) 160.9 ± 40.7 132.1 ± 29.9
CS1  (case, %) 411 (66.2%) 32 (32.3%) 
CS2  (case, %) 179 (28.8%) 55 (55.6%) 
CS3  (case, %) 31 (5.0%) 12 (12.1%) 
Heart rate (beats/min) 113.1 ± 30.6 108.5 ± 32.8
LVEF  (%) on admission 37.0 ± 16.2 36.4 ± 17.0
Past  medical history
Hypertension (case, %) 446 (71.8%) 58 (58.6%) 
Diabetes mellitus (case, %) 236 (38.0%) 35 (35.4%) 
Dyslipidemia (case, %) 255 (41.1%) 31 (31.3%) 
BC, white blood cell; CRP, C-reactive protein; BUN, blood urea nitrogen; BNP, brain nat
S, clinical scenarios; CS1, systolic blood pressure (SBP) on admission > 140 mmHg; CS2, 1
VEF,  left ventricular ejection fraction measured by echocardiogram on admission.
 value, comparison with alkalosis, normal acid–base balance and acidosis groups by the heere–Terpstra test.
The relationship between the patient characteristics, including
medications prescribed during the ﬁrst ﬁve days, and the acid–base
balance is shown in Table 3. Dopamine and dobutamine were used
more frequently during the acute phase in the alkalosis group,
and angiotensin-converting enzyme inhibitor/angiotensin recep-
tor blockers, statins, and -blockers were used less frequently
in the alkalosis group during the acute phase than in acidosis
group.
Acid–base balance and outcome
The length of intensive care unit hospitalization and total hos-
pitalization showed no difference between the three groups. The
in-hospital mortality rate was signiﬁcantly higher in the alkalosis
group (14.1%) than in the normal (4.5%) and acidosis groups (9.3%;
Table 3).The results of the multivariate logistic regression model for
in-hospital mortality found that the speciﬁc factors were orthop-
nea [yes; p = 0.023, odds ratio (OR): 3.111; 95% conﬁdence interval
(CI): 1.165–8.306], creatinine (>1.10 mg/dl; p = 0.004, OR: 3.069;
99) Normal (n = 178) Acidosis (n = 344) p value
 71.3 ± 13.5 72.8 ± 10.4 n.s.
137 (77.0%) 250 (72.7%) n.s.
104 (58.4%) 200 (58.1%) n.s.
123 (69.1%) 221 (64.2%) n.s.
124 (69.7%) 324 (94.2%) <0.001
9,290 ± 3,585 11,833 ± 6,441 <0.001
1 1.76 ± 3.5 1.35 ± 2.78 <0.001
1 6.59 ± 0.66 6.88 ± 0.69 <0.001
2 3.66 ± 0.47 3.81 ± 0.48 <0.001
 26.5 ± 13.5 26.9 ± 16.3 n.s.
9 1.28 ± 0.77 1.46 ± 0.98 n.s.
139.9 ± 3.5 139.3 ± 4.3 0.005
6 4.23 ± 0.62 4.39 ± 0.77 0.026
12.8 ± 2.7 12.8 ± 2.8 n.s.
7 0.86 ± 1.34 0.64 ± 0.52 <0.001
 173.7 ± 80.7 243.3 ± 95.7 <0.001
0 6.93 ± 2.27 6.82 ± 2.13 n.s.
.6 1014.8 ± 1124.8 1010.4 ± 984.7 n.s.
 154.5 ± 31.7 172.5 ± 42.7 <0.001
115 (64.6%) 264 (76.7%)
58 (32.6%) 66 (19.2%) <0.001
5 (2.8%) 14 (3.9%)
 108.2 ± 32.2 117.0 ± 28.5 <0.001
 37.9 ± 16.3 36.7 ± 16.0 n.s.
124 (69.7%) 264 (76.7%) 0.001
62 (34.8%) 139 (40.4%) n.s.
66 (37.1%) 158 (45.9%) 0.015
riuretic peptide.
00 mmHg   SBP on admission  140 mmHg; CS3, SBP on admission < 100 mmHg.
Jonckheere–Terpstra test.
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pig. 1. The relationship between the acid–base balance and clinical information an
lood  pressure (SBP) had a signiﬁcant negative correlation with the pH value (p < 0
ilirubin (T-bil) were signiﬁcantly correlated with the pH value (p < 0.001, r = 0.365)
5% CI: 1.421–6.630), and alkalosis (p = 0.017, OR: 2.589; 95% CI:
.186–5.648; Table 4).
There were 113 deaths among the 621 patients (18.2%) within 2
ears. The Kaplan–Meier curves showed that the prognosis with
egard to any-cause death was signiﬁcantly poorer among the
atients with alkalosis in comparison with the patients who had
ormal acid–base balance (p = 0.026, Fig. 2A), furthermore, the
rognosis was not different between the patients with acidosis and
ormal acid–base balance (Fig. 2B).
able 3
anagement of acute heart failure and outcomes.
Characteristics All (n = 621) Alkalosis (n = 99
Respirator management in ER
Ventilator (cases, %) 178 (28.7%) 15 (15.2%) 
NPPV (cases, %) 188 (30.3%) 16 (16.2%) 
Medication (cases) during 5 days
Furosemide (cases, %) 594 (95.7%) 94 (94.9%) 
Nitroglycerin (cases, %) 460 (74.1%) 55 (55.6%) 
Nicorandil (cases, %) 76 (12.2%) 12 (12.1%) 
Carperitide (cases, %) 345 (55.6%) 44 (44.4%) 
Dopamine (cases, %) 203 (32.7%) 33 (33.3%) 
Dobutamine (cases, %) 147 (23.7%) 22 (22.2%) 
ACE-I/ARB (cases, %) 255 (41.1%) 29 (29.3%) 
-blocker (cases, %) 129 (21.0%) 15 (15.2%) 
Statin (cases, %) 183 (29.5%) 20 (20.2%) 
Spironolactone (cases, %) 222 (35.7%) 35 (35.4%) 
Hospital stay
ICU hospitalization (days) 8.1 ± 14.2 7.9 ± 10.4 
Total  hospitalization (days) 39.7 ± 42.8 36.3 ± 24.0 
In-hospital mortality (cases, %) 54 (8.7%) 14 (14.1%) 
R, emergency room; NPPV, non-invasive positive pressure ventilation.
CE-I, angiotensin-converting enzyme inhibitor; ARB, angiotensin II receptor blocker; ICU
 value, comparison with alkalosis, normal acid–base balance and acidosis groups by the l signs. (A, B, D) The serum levels of white blood cells (WBC), glucose, and systolic
WBC: r = −0.416, glucose: r = −0.507, SBP: r = −0.380). (C) The serum levels of total
Discussion
The present study showed the factors associated with acido-
sis upon the patients’ arrival to the emergency department to be
a high WBC  and high glucose, and the speciﬁc vital signs were
a high SBP and fast HR. Almost all patients had orthopnea. They
suggested that the duration of decompensation might be short in
patients with acidosis AHF. Furthermore, treatment strategies were
established in acidosis acute-onset patients. As a result, the patients
) Normal (n = 178) Acidosis (n = 344) p value
19 (10.7%) 144 (41.9%) <0.001
47 (26.4%) 125 (36.3%) <0.001
168 (94.4%) 332 (96.5%) n.s.
127 (71.3%) 278 (80.8%) <0.001
22 (12.4%) 42 (12.2%) n.s.
128 (54.9%) 215 (62.5%) <0.001
45 (23.3%) 125 (36.3%) 0.038
27 (15.2%) 98 (28.5%) 0.003
91 (51.1%) 135 (39.2%) 0.001
30 (16.9%) 84 (24.4%) n.s.
47 (26.4%) 116 (33.7%) 0.020
68 (38.2%) 119 (34.6%) 0.042
7.5 ± 12.9 8.4 ± 15.7 n.s.
37.1 ± 36.1 42.0 ± 49.6 n.s.
8 (4.5%) 32 (9.3%) 0.020
, intensive care unit.
Jonckheere–Terpstra test.
292 A. Shirakabe et al. / Journal of Cardiology 60 (2012) 288–294
(%) (%)
BA
p=0.026
Normal (n =178) 
80
p=n.s.
Acidosis (n= 344)
Normal (n=178)
80
Alkalosis (n=  99)
S
u
rv
iv
a
l 
ra
te
40
S
u
rv
iv
a
l 
ra
te
40
days
0
2000 400
Follow-up Periods 
600 800 days
0
2000 400
Follow-up Periods 
600 800
200 40 0 73 0
Norma l 11 1 83 57
Alkalosi s 63 53 42
days
cases
cases
200 40 0 73 0
Normal 11 1 83 57
Acidosi s 20 5 16 4 11 7
days
cases
cases
F A) The
a 6). (B)
a
w
m
A
p
g
r
T
C
i
(
o
e
t
k
i
p
h
e
p
t
p
p
w
t
T
M
Oig. 2. The Kaplan–Meier curves of the prognosis with regard to any-cause death. (
lkalosis in comparison with the patients who had a normal acid-balance (p = 0.02
cid-balance.
ith acidosis were not associated with short-term and long-term
ortality. On the other hand, the factors associated with alkalosis
HF patients include a high CRP and high total bilirubin, and these
atients also had low total protein and albumin levels, thus sug-
esting that they had experienced HF for a few days. It was one
eason that the mortality was high in the alkalosis AHF patients.
hese clinical implications are important for the treatment of AHF.
linical implication of the present study
The word “acute” in the context of AHF has become confus-
ng because some clinicians use the word to indicate severity
the medical emergency of life-threatening pulmonary edema) and
thers use the word to indicate decompensated, resent onset, or
ven new onset HF. The word is then an indicator of time rather
han severity [1].  Therefore, the components of AHF include many
inds of HF. ESC guidelines proposed a clinical classiﬁcation of AHF
nto ﬁve well-established categories, peripheral edema/congestion,
ulmonary edema, cardiogenic shock (low output syndromes),
igh blood pressure (hypertensive HF), and right HF. Peripheral
dema/congestion and right HF are classiﬁed as leisurely onset
resentation, and pulmonary edema, high blood pressure (hyper-
ensive HF) are classiﬁed as abrupt-onset presentation. These AHF
atients present at the emergency department suddenly com-
lained about dyspnea due to various causes.
The type of respiratory function disturbances vary in patients
ith AHF, especially, ventilation disorder, diffusion disorder such as
he replacement of air in the lungs by blood through the interstitial
able 4
ultivariate study of in-hospital mortality.
Information In-hospital mortality
OR 95%CI p value
Orthopnea 3.111 1.165–8.306 0.023
Serum creatinine > 1.10 mg/dl 3.069 1.421–6.630 0.004
Alkalosis 2.589 1.186–5.648 0.017
R, odds ratio; CI, conﬁdence interval. prognosis with any-cause death was signiﬁcantly poorer among the patients with
 Furthermore, it was not different between the patients with acidosis and normal
ﬂuid. Alveolar and pulmonary venous congestion causes diffusion
disorder associated with CO2 retention [10]; as a result the patients
tend to develop respiratory acidosis. The patients with clinical
abrupt-onset presentation, such as acute pulmonary edema and
hypertensive HF, reveal dyspnea caused by mainly alveolar and
pulmonary congestion, which leads to acidosis. On the other hand,
the patients with pleural effusion could replace the air in the lungs
by blood through the interstitial ﬂuid; however, they had ventila-
tion disorder and they therefore could not get enough tidal volume
caused by pleural effusion. They needed to increase ventilation to
compensate this situation. Thus, pleural effusion causes ventila-
tion disorder associated with CO2 reduction [11]; as a result, the
patients tend to develop respiratory alkalosis. Patients with clinical
gradual-onset presentation, such as peripheral edema/congestion
and right HF reveal dyspnea caused mainly by pleural effusion,
which leads to alkalosis. Patients with severe chronic HF before
heart transplantation show high-normal pH and slightly reduced
pCO2 [12]. Some data were not collected from all patients; however,
the patients with acidosis had less pleural effusion in comparison
to the alkalosis patients by chest X-ray in present study.
The present study may  therefore support the hypothesis that the
patients with acidosis were abrupt-onset cases, while the patients
with alkalosis were gradual-onset cases. The ESC guidelines explain
the initial diagnostic evaluation of patients with AHF to include
a full blood count, sodium, potassium, urea, creatinine, glucose,
albumin, and hepatic enzymes [1].  We therefore use these routine
laboratory tests to evaluate the patients’ ﬁrst condition.
The serum levels of glucose have been shown to increase due
to acute stress in critically ill patients in the intensive care unit
[13–16] and also increase at the exacerbation of HF by the secre-
tion of endogenous catecholamine and cortisol [17]. The WBC  count
is also a classical marker of systemic inﬂammation, and is increased
by acute stress in these patients, such as acute myocardial infarction
and aortic dissection [15–18].  The WBC  counts also increase at the
exacerbation of HF because inﬂammatory processes are involved
with HF worsening [19,20]. Their increase in HF demonstrates clin-
ical abrupt-onset presentation HF, such as acute pulmonary edema
or hypertensive HF. The present study found WBC  and glucose was
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ncreased in acidosis patients, therefore, acidosis patients were
ore likely to have abrupt-onset HF, such as acute pulmonary
dema or hypertensive HF. Actually, the SBP was  signiﬁcantly
igher in the acidosis group than in the alkalosis group, thus sug-
esting that there were more patients with hypertension among
he acidosis patients.
In contrast, the serum levels of CRP and total bilirubin were
igh in patients with alkalosis, thus alkalosis HF patients might be
atients with clinical gradual-onset presentation, such as periph-
ral edema/congestion or right HF. The WBC  counts reﬂect the rapid
ncrease in systemic inﬂammation, and the serum levels of CRP
lso increased a few days later after the systemic inﬂammation;
herefore, the serum levels of CRP were considered to be positively
orrelated with the acid-balance. CRP is a marker of long-term
evelopment of HF and mortality in patients with acute myocardial
nfarction, and high sensitivity CRP levels independently predicted
ospitalization in patients with systolic HF [21,22]. The increase
n the serum CRP level might inﬂuence the poorer outcome in the
lkalosis HF patients.
On the other hand, no correlation was found between the
cid–base balance and the renal function. In general, a declining
enal function leads to metabolic acidosis. Most of the population
n the present study was found to have respiratory acidosis, and
ntermixed with metabolic acidosis as shown in Table 1. This mix
f different types of acidosis might be the main reason that no cor-
elation was observed between the acid–base balance and the renal
unction.
he prognosis in patients with AHF
Fonarow and co-workers reported that renal function (blood
rea nitrogen, creatinine levels) and the SBP were the three vari-
bles most predictive of in-hospital mortality in the Organized
rogram to Initiate Lifesaving Treatment in Hospitalized Patients
ith Heart Failure (OPTIMIZE-HF) registry [23], and another report
emonstrated the importance of the prognostic value of SBP and
enal function [24,25]. The present study found that the serum lev-
ls of creatinine were also an independent risk factor for in-hospital
ortality.
The prognostic value of the acid–base balance in patients with
HF has not been thoroughly considered. Admission pO2, pCO2, and
H are not associated with all-cause long-term mortality [6].
Acid–base balance in AHF is inﬂuenced by many factors and
ndividuals. The majority of acidosis patients in the current study
ad respiratory acidosis (Table 1), and did not have a poor prog-
osis. In general, acidosis is a poor prognostic factor for intensive
are patients, especially among those with postoperative pneu-
onia [26], acute lung injury/acute respiratory distress syndrome
27], and surgical intensive care patients [28]. Gas exchange dis-
urbances are transitory and reversible in patients with AHF.
he treatment strategy was determined for patients with clini-
al abrupt-onset presentation, such as acute pulmonary edema or
ypertensive HF. In our institute, a medical specialist can treat these
atients immediately at our emergency department all day, and
ontinuous positive airway pressure could be tried on all patients.
hile patients often do not cooperate with face mask attachment, it
s strongly attached by many physicians or bi-level positive airway
ressure is achieved with a small amount of sedation for example
f morphine. The success of non-invasive positive pressure ven-
ilation is largely due to the skill of the medical team in treating
atients [29]. Nitroglycerine is also administered to reduce the
fter-load. The prognosis of acidosis patients might be improved
y these established strategies. High mortality rates are observed
n other AHF in comparison to abrupt dyspneic presentations of
HF, such as acute pulmonary edema or hypertensive HF [25–30].diology 60 (2012) 288–294 293
On the other hand, the patients with alkalosis were het-
erogeneous. They were admitted with clinical gradual-onset
presentation, such as peripheral edema/congestion or right HF with
lung pleural effusion. It is difﬁcult to determine the onset time for
these patients. They were usually late admission, and their treat-
ment strategy was  not determined by the patients’ condition. The
alkalosis group presented less acutely ill appearing with a more
sub-acute course, and had a lower rate of orthopnea. It might lead to
less aggressive therapy from the early stage and higher in-hospital
mortality. The administration of carperitide and statin, which is
reported to lead to a better prognosis in AHF [31,32] signiﬁcantly
decreased in alkalosis patients. The alkalosis AHF therefore might
lead to a poor prognosis. In addition to the clinical, radiologic,
electrocardiographic, and biomarker evaluation, ABG results might
provide any additional prognostic utility to the ESC and ACCF/AHA
recommendations.
Study limitations
There are several limitations associated with this study. First,
determination of brain natriuretic peptide and other biomarker-
related variables were not assessed on all patients’ arrival
to the emergency department. This fact precludes their use
in the multivariable model. Second, most patients underwent
transthoracic echocardiography at the time of admission and
after HF was  stabilized, however it was  difﬁcult to compare
these data because they were recorded under different condi-
tions. The dimensions could not be accurately recorded in the
emergency setting with orthopnea. Third, the patients with car-
diogenic shock were reported to reveal poor tissue perfusion
with lactate acidosis, and renal dysfunction with metabolic aci-
dosis. They hyperventilate to compensate for the presence of
metabolic acidosis, and therefore CO2 reduction normally occurs
with acidosis. In the present study, we  could not get a lac-
tate sample from all patients. Fourth, the present study was
a single center study, with a small number of patients included in
each of the groups used to evaluate the prognosis, therefore, there
might be a patient bias. For example, the SBP was relatively high in
comparison to other HF registries [24,33],  the rate of new-onset HF
was high at 72.5%, the mortality rate was low at 8.7% (in-hospital
mortality), 18.2% (2 year mortality), and the etiology of HF was
mixed.
Conclusions
The factors associated with alkalosis AHF were high CRP, biliru-
bin, and low WBC, glucose, total protein, and albumin. The patients
with alkalosis AHF were less likely to have orthopnea with low
SBP and HR. They suggested that the patients with alkalosis AHF
might have experienced HF for a few days and were associated with
high mortality. These clinical implications are thus considered to be
important for the treatment of AHF.
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